Skip to content
Aperlena
Free alerts

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 day ago Contract notice

Germany - Medicinal products - Open-house biosimilar discount agreements 2025-31 - Denosumab

Original Deutschland - Arzneimittel - Open-House-Biologika-Rabattverträge 2025-31 - Denosumab

Open Germany Hamburg Medical equipment & pharmaceuticals

Buyer Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse

421 days left

Key facts

Closes
23:58 (UTC+1)
Procedure
Open procedure
  1. Published
  2. Today
  3. Deadline open for 771 days
  4. Awarded pending
View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

Summary

Machine-generated summary

The participating statutory health insurance funds intend to conclude rebate agreements under Section 130a(8) SGB V with all suitable pharmaceutical entrepreneurs for the active substance denosumab, within an open-house biosimilar procedure. The procedure is divided into two lots for this active substance, with details given for each lot. No individual negotiations take place; uniform conditions apply and no exclusivity is granted to individual contracting partners. Contracts run for a maximum of 24 months starting on 01.12.2025 and end no later than 30.11.2027, regardless of the date of signature. Companies may join the open-house procedure at any time during the contract term. Further information is contained in the participation and contract documents.

Description

Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Denosumab zu schließen. Das Verfahren wird in zwei Lose zum genannten Wirkstoff aufgeteilt. Zu den Einzelheiten siehe Angaben beim jeweiligen Los. Der Vertragsschluss erfolgt im Rahmen des Open-House-Biologika-Verfahrens der beteiligten Kassen: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die beteiligten Krankenkassen sichern einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.12.2025. Der Vertrag endet spätestens am 30.11.2027, unabhängig vom Datum des Vertragsschlusses. Ein Beitritt zu diesem Open-House-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Die gemachten Angaben zur Bindefrist sind vorliegend nicht relevant und ausschließlich den zwingenden Vorgaben des Formulars geschuldet. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen. Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Denosumab im Rahmen eines Open-House-Verfahrens. Bitte beachten Sie die vorgenommene Losaufteilung des Wirkstoffs.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    421 days left, 301 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    In this country this kind of contract is usually awarded for between €215,780 and €1.0M.

  6. Your call:

    Do we know this buyer?

    The register holds nothing on this. The official documents will.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

View the official notice

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 310 awards for Medical equipment & pharmaceuticals in Germany.

Median award
€377,880
Middle half of past awards
€215,780 to €1.0M

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse

Germany

Who wins its contracts

of its calls state an estimated value
0%

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 86 €30.9M Oct 2026
Philips GmbH 31 €9.0M Sep 2026
Brainlab Sales GmbH 21 €8.5M Sep 2026
Intuitive Surgical Deutschland GmbH 16 €22.7M Sep 2026
Philips GmbH Market DACH 16 €8.0M Jul 2026

Based on 1512 awards with a linked company profile over the last 2 years.

23 open tenders right now

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
10,903
median open notice
€143,339

Who wins in this market

Many suppliers

Germany · Medical equipment & pharmaceuticals

different companies won awards here
809
of the awards went to the three most frequent winners
9%
buyers awarded contracts here
441

Based on 1,512 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
12.2
of those lots received a single tender
16%
of the awards went to companies based in another country
7%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

1,821 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

421 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language